GLP-1 drugs are changing how Americans eat. Food companies are racing to catch up

Photo credit: Haberdoedas via Unsplash. Article by Amelia Lucas. CNBC – March 21, 2026.

The cost of GLP-1 drugs is falling, and pill versions are hitting the U.S. market. For restaurant chains and snacking giants, higher adoption of weight loss and diabetes treatments poses a threat to their sales — or an opportunity. GLP-1 drugs slow digestion, suppress users’ appetites and increase satiety. For many restaurants and packaged food manufacturers, those reactions will likely mean weaker sales. Adults who use GLP-1s consume 21% fewer calories and spend nearly a third less on grocery bills on average, according to KPMG. […]

Click here to view original web page at www.cnbc.com